S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
BREAKING: Tiny biotech successfully treats blindness (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
With oil prices slumping, OPEC+ producers weigh more production cuts
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
BREAKING: Tiny biotech successfully treats blindness (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
With oil prices slumping, OPEC+ producers weigh more production cuts
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
BREAKING: Tiny biotech successfully treats blindness (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
With oil prices slumping, OPEC+ producers weigh more production cuts
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Apple is expected to unveil sleek headset aimed at thrusting the masses into alternate realities
BREAKING: Tiny biotech successfully treats blindness (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
With oil prices slumping, OPEC+ producers weigh more production cuts
NYSE:MPW

Medical Properties Trust (MPW) Price Target & Analyst Ratings

$8.25
+0.08 (+0.98%)
(As of 06/2/2023 ET)
Compare
Today's Range
$8.23
$8.53
50-Day Range
$7.26
$8.77
52-Week Range
$7.10
$17.96
Volume
12.41 million shs
Average Volume
14.28 million shs
Market Capitalization
$4.94 billion
P/E Ratio
16.50
Dividend Yield
14.06%
Price Target
$13.23

Medical Properties Trust Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$13.23
60.37% Upside
High Prediction$18.00
Average Prediction$13.23
Low Prediction$9.00
TypeCurrent
6/4/22 to 6/4/23
1 Month Ago
5/5/22 to 5/5/23
3 Months Ago
3/6/22 to 3/6/23
1 Year Ago
6/4/21 to 6/4/22
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.23$13.23$15.36$23.11
Predicted Upside60.37% Upside26.16% Upside18.63% Upside10.48% Upside
Get Medical Properties Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MPW and its competitors with MarketBeat's FREE daily newsletter.


MPW Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MPW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medical Properties Trust Stock vs. The Competition

TypeMedical Properties TrustFinance CompaniesS&P 500
Consensus Rating Score
2.45
2.41
2.49
Consensus RatingHoldHoldHold
Predicted Upside60.37% Upside311.70% Upside209.76% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/28/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$14.00 ➝ $12.00+39.70%
4/19/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$9.00+6.13%
4/5/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$14.00 ➝ $12.00+47.78%
4/4/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$16.00 ➝ $15.00+85.19%
3/31/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$8.00 ➝ $9.00+11.94%
3/16/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$10.00+22.70%
3/7/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$11.00+9.34%
3/3/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$14.00 ➝ $12.00+13.42%
3/2/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetStrong-Buy$18.00 ➝ $16.00+59.05%
12/2/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$20.00 ➝ $18.00+39.00%
10/4/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$20.00 ➝ $18.00+55.84%
9/16/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$17.00 ➝ $15.00+9.57%
6/30/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$19.00 ➝ $15.00-4.94%
(Data available from 6/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












MPW Price Target - Frequently Asked Questions

What is Medical Properties Trust's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Medical Properties Trust stock is Hold based on the current 7 hold ratings, 3 buy ratings and 1 strong buy rating for MPW. The average twelve-month price prediction for Medical Properties Trust is $13.23 with a high price target of $18.00 and a low price target of $9.00. Learn more on MPW's analyst rating history.

Do Wall Street analysts like Medical Properties Trust more than its competitors?

Analysts like Medical Properties Trust more than other Finance companies. The consensus rating score for Medical Properties Trust is 2.45 while the average consensus rating score for finance companies is 2.41. Learn more on how MPW compares to other companies.

Is Medical Properties Trust being downgraded by Wall Street analysts?

Over the previous 90 days, Medical Properties Trust's stock had 1 downgrade by analysts.

Does Medical Properties Trust's stock price have much upside?

According to analysts, Medical Properties Trust's stock has a predicted upside of 26.16% based on their 12-month price targets.

What analysts cover Medical Properties Trust?

Medical Properties Trust has been rated by Bank of America, Barclays, Credit Suisse Group, KeyCorp, Stifel Nicolaus, Truist Financial, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:MPW) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -